Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com

Stock Price vs Company Growth
1d
1.5%
1w
0.1%
1m
1.3%
3m
5.8%
6m
17.1%
1y
15.8%
all
7.9%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowSep20Sep21Sep22Sep23Sep24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

908 1.5%
885
1,078
Company Overview

Sales
2,481 Cr
Growth: 5.6%
Profit after Tax
530 Cr
Growth: 7.0%
Mid Cap
11,140 Cr
P/E: 21.0x
Industry P/E: 32.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 2,481
Growth 5.6%
EBITDA 29.8%
P/S 4.5x
Dividend 0.0%
P/E 21.0x
Book Value ₹ 250
PEG Ratio 3.7x
ROE 18.4%
P/B 3.6x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Dec21Mar22Sep22Jun23Sep23Mar24Jun24Sep24Dec24Jun25
Promoters
Created with Highcharts 8.2.2Dec21Mar22Sep22Jun23Sep23Mar24Jun24Sep24Dec24Jun25
Others
Created with Highcharts 8.2.2Dec21Mar22Sep22Jun23Sep23Mar24Jun24Sep24Dec24Jun25
Increase    Decrease    No change
Company Profile Detailed

The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Investors (6)
Followers (2)